Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Laser, Radiofrequency, and Promestriene for Vulvovaginal Atrophy in Breast Cancer
NCT04081805Active, not recruiting
- Sponsor
- Federal University of São Paulo
- Start
- Sep 2019
- Primary completion
- Sep 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (3 arms), sponsored by Federal University of São Paulo. Primary endpoints: Clinical Improvement of signs and symptoms of vulvovaginal atrophy at 90 days and Satisfaction with treatment at 90 days. Started Sep 2019; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04081805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04081805.